Search
News
International Conference Features UCSF Breast Cancer Experts
Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference.
News
Life-Changing Care for Pelvic Organ Prolapse: UCSF Case Study
Symptoms of pelvic floor disorders, such as pelvic organ prolapse and urinary and fecal incontinence, can significantly hinder quality of life.
News
UCSF Urology Experts Highlight Leadership in Innovative Research and Treatment at National Urology Conference
Using artificial intelligence (AI) to improve prediction of prostate cancer treatment response and biomarkers to enhance prostate cancer diagnosis were among the topics discussed by UCSF clinicians at the American Urological Association’s 2025 annual meeting.
News
UCSF Among First in U.S. to Receive New Pulmonary Care Designation
UCSF has been designated a Bronchiectasis and NTM Care Center, based on the depth and breadth of its services.
News
How Hungry Fat Cells Could Someday Starve Cancer to Death
Scientists transformed energy-storing white fat cells into calorie-burning ‘beige’ fat.
News
One Gene Variant Is Poised to Cure Devastating COPA Syndrome
Scientists compared five families and multiple generations to find a gene variant that prevents COPA Syndrome and opens the door to a new gene therapy for the condition.
News
How a Paralyzed Man Moved a Robotic Arm Using a Brain-Computer Interface
Researchers at UC San Francisco have enabled a man who is paralyzed to control a robotic arm that receives signals from his brain via a computer.
News
Stephen Hauser Wins Breakthrough Prize for Role in Redefining MS
Neuro-immunologist Stephen Hauser, MD, whose maverick thinking transformed the treatment landscape for patients with multiple sclerosis (MS), has received the 2025 Breakthrough Prize in Life Sciences.
News
New Discovery Reveals Pathway to Modulate Scarring in Spinal Cord Injury
After a spinal cord injury, nearby cells quickly rush to action, forming protective scar tissue around the damaged area to stabilize and protect it
News
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the world came together for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest developments in cancer care, research, technology and education.
News
Scientists Discover a New Hormone that Can Build Strong Bones
A newly discovered hormone that keeps the bones of breastfeeding women strong could also help bone fractures heal and treat osteoporosis in the broader population.
News
Medical Trainees May Be Exposed to Unnecessary Radiation Risks
Radiation from X-rays is an occupational hazard for many medical specialists, including cardiologists, vascular and orthopedic surgeons, urologists, some radiologists and gastroenterologists.
News
Scientists Discover How to Make Ordinary Fat Cells Burn Calories
Researchers at UC San Francisco have figured out how to turn ordinary white fat cells, which store calories, into beige fat cells that burn calories to maintain body temperature.
News
Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference...
News
Can a New Drug Candidate Cure Pancreatic Cancer?
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
News
Prostate Cancer Test Is Missing Early Disease in Transgender Women
Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC San Francisco.
News
Algorithm Improves Blood Sugar Control in Hospitalized Patients
Controlling blood sugar in the hospital setting is challenging for a variety of reasons including inconsistent caloric intake, changes in kidney and liver function, surgery, infections, and limitations in labor-intensive glucose monitoring and insulin administration.
News
How AI Can Help Streamline Patient Referrals and Expedite Cancer Treatment
UCSF investigators recently partnered with IIAM Corporation to determine whether a supervised machine learning (ML) model accurately predicts whether patients with head and neck cancer should be recommended for surgery based on the medical information provided at the time of referral.
News
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
News
New Alzheimer’s Trial to Combine Anti-Amyloid and Anti-Tau Therapies to Arrest Disease Progression
A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two drugs that target disease-driving proteins to see whether their effects can be amplified.
News
Adult Acquired Buried Penis: Improving Patient Outcomes
Adult-acquired buried penis (AABP) is a condition in which excess or abnormal surrounding soft tissue covers the penis, resulting in sexual and urinary dysfunction. While it’s associated with obesity, AABP does not typically subside with weight loss.
News
How a Cutting-Edge Genetic Test Helps Ill Newborns, Pregnant Moms
UCSF is first in Northern California to offer rapid test in-house for faster and more accurate diagnosis of rare genetic conditions.
News
Physician Survey Shows Lack of Understanding of the FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than they are, according to a national survey of physicians conducted by researchers at UC San Francisco (UCSF).
News
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
